Journal of Laboratory Medicine

Journal of Laboratory Medicine, published in Berlin by De Gruyter since 2019, is a bimonthly open access journal of clinical laboratory diagnostics issued for the German Society of Clinical Chemistry and Laboratory Medicine and affiliated with the Austrian Society of Laboratory Medicine and Clinical Chemistry. Its 2025 Journal Impact Factor is 1.9, which places it Q3 (18 of 33) among medical laboratory technology titles in SCIE.《检验医学杂志》2019 年起由 De Gruyter 在柏林出版，是一份双月刊金色开放获取刊物，主题为临床实验室诊断，系德国临床化学与检验医学会的官方期刊，并与奥地利检验医学与临床化学学会结盟。2025 年影响因子为 1.9，在 SCIE 医学实验技术类目列 Q3，排名 18/33。

Scope

• The stated objective runs across the diagnostic, clinical, methodological and pathogenic sides of the modern laboratory, together with the technical, regulatory and educational questions that decide how a result is produced and read.宗旨页把范围划在四个方面，现代实验室的诊断价值，临床解释，方法学基础与致病机制，此外还有决定结果如何产生与解读的技术、法规与教育议题。
• Preanalytical work holds a standing place, covering specimen collection and transport, haemolysis and interference, the stability of analytes and the traceability of every step that comes before the analyser.分析前环节长期占据版面，标本采集与运送，溶血与干扰，待测物的稳定性，以及进入分析仪之前每一步的可追溯性，都在讨论之列。
• Method evaluation is handled as measurement science, with papers on validation protocols, uncertainty budgets, reference intervals and the harmonisation of units so that figures from different platforms can be set side by side.方法评价按计量学标准处理，验证方案，不确定度预算，参考区间的建立与跨平台单位的协调各有专文，不同仪器给出的数字因此可以并置比较。
• Molecular diagnostics form a large strand, from polymerase chain reaction and sequencing to copy number work, rare variant interpretation and the reporting language that clinicians need in order to act on a genetic finding.分子诊断构成一大板块，从聚合酶链反应与测序，到拷贝数分析，罕见变异解释，以及临床医生据以处置遗传学发现所需的报告用语，均有涉及。
• Clinical chemistry covers the routine menu and its edges, including cardiac markers, tumour markers, glucose and lipid testing, kidney function, electrolyte disturbance and the use of serial results to follow a course of treatment.临床化学覆盖常规项目及其边界，心肌标志物，肿瘤标志物，血糖与血脂，肾功能，电解质紊乱，以及用连续结果追踪疗程的做法，都在其中。
• Haematology and haemostasis are served by work on blood counts, morphology, flow cytometry, platelet function, anticoagulant monitoring and the laboratory side of thrombophilia investigation.血液学与止血学有专门版面，血细胞计数，形态学，流式细胞术，血小板功能，抗凝药物监测与易栓症检查中的实验室环节，各自成题。
• Immunological testing receives the same care, spanning autoantibody profiles, allergy diagnostics, complement, immunoglobulin measurement and the follow-up of patients whose immune defence is failing.免疫学检验按同等标准处理，自身抗体谱，过敏诊断，补体，免疫球蛋白测定，以及免疫防御受损患者的随访，都是常见题目。
• Infection diagnostics keep a firm foothold, with culture and susceptibility work, mass spectrometric identification, molecular panels for sepsis and the reporting of resistance that guides empirical prescribing.感染诊断根基稳固，培养与药敏，质谱鉴定，脓毒症的分子检测组合，以及指导经验性用药的耐药性报告，都在这一支里。
• Mass spectrometry and chromatography carry therapeutic drug monitoring, toxicology, steroid profiling and the small-molecule work that classical immunoassays cannot resolve, often with method comparison against established platforms.质谱与色谱承担治疗药物监测，毒物分析，类固醇谱，以及传统免疫法难以分辨的小分子测定，方法比对常与既有平台平行进行。
• Point-of-care testing is examined where it is used, in emergency departments, wards and doctors' offices, with attention to device evaluation, operator training, connectivity and the quality control that keeps a near-patient result trustworthy.床旁检测放在使用现场考察，急诊，病房与诊室都是观察点，仪器评价，操作者培训，数据互联与维持结果可信的质量控制，一并讨论。
• Automation and laboratory information technology are followed closely, from track systems and autoverification rules to middleware, data standards and the audit trail that a laboratory must be able to show an inspector.自动化与实验室信息技术受到密切关注，从流水线与自动审核规则，到中间件，数据标准，以及实验室须向检查员出示的审计轨迹，均有涉及。
• Quality management is a recurring subject, covering accreditation against ISO 15189, internal quality control, external assessment schemes, incident reporting and the organisational side of patient safety in the laboratory.质量管理是反复出现的题目，ISO 15189 认可，室内质控，室间质评计划，事件报告，以及实验室患者安全的组织层面，都有专门讨论。
• Guidelines and recommendations of the two sponsoring societies appear among the articles, so that a pathway proposed by a working group reaches the people who will apply it in a routine service.两家主办学会的指南与建议常在刊内发表，工作组提出的诊断路径因此能直接送到日常服务中使用它的人手里。
• Training and continuing education belong to the scope as well, with papers on curricula for laboratory physicians, competence assessment and the teaching of interpretation rather than of technique alone.培养与继续教育同样在范围之内，实验室医师的课程设置，能力评估，以及侧重结果解读而非单纯操作的教学办法，都有专文。
• Formats run from original research and systematic review to case reports, point and counterpoint exchanges and letters to the editor, each with its own length and structure in the author instructions.体裁从原创研究与系统综述，延伸到病例报告，正反方对话与致编辑信，作者指南为各类稿件分别规定篇幅与结构。

History

• The present title dates from 2019, when De Gruyter relaunched the journal in English with the ISSN pair 2567-9430 and 2567-9449 and opened at volume 43.现刊名始于 2019 年，De Gruyter 以英文重办该刊，启用 2567-9430 与 2567-9449 这对刊号，卷次从第 43 卷接续。
• Its predecessor was LaboratoriumsMedizin, a German-language journal whose Crossref record runs from 1977 to 2018 under ISSN 0342-3026, with a parallel electronic number 1439-0477.前身是德文刊《LaboratoriumsMedizin》，其 Crossref 记录自 1977 年延续到 2018 年，印刷刊号 0342-3026，另配电子刊号 1439-0477。
• Volume numbers make the handover plain. The old series closed with volume 42 in 2018, the new one opened with volume 43 a year later, and no gap or restart appears in between.卷号把这次交接写得很清楚，旧刊在 2018 年以第 42 卷收尾，新刊一年后从第 43 卷开始，中间既无空缺也无重起。
• National library records date the first volume to 1977, so the numbering inherited in 2019 carries more than four decades of continuous publication behind it.国家图书馆的书目记录把第 1 卷定在 1977 年，2019 年继承下来的卷号背后，因此有四十余年的连续出版史。
• Six issues a year have been the pattern throughout the present series. Volumes 43 to 50 all carry issues 1 to 6, which settles a discrepancy between two published frequency statements.现行系列始终按每年六期出刊，第 43 卷至第 50 卷都编到第 6 期，两种彼此矛盾的刊期说法由此可以判定。
• Berlin is the place of publication and Walter de Gruyter the imprint throughout, now trading as De Gruyter Brill after the merger of the two houses.出版地一直在柏林，出版方自始至终是 Walter de Gruyter，两家出版社合并后以 De Gruyter Brill 的名义经营。
• Ownership sits with a society rather than a commercial body. The journal is the official organ of the German Society of Clinical Chemistry and Laboratory Medicine and is affiliated with the Austrian society of the same field.刊物的归属在学会而非商业机构，它是德国临床化学与检验医学会的官方期刊，并与奥地利同领域学会结盟。
• Open access was the model from the relaunch. Authors' institutions, funders or sponsors meet an article processing charge, and an unrestricted educational grant from the German society covers part of the cost.重办之初就采用开放获取，文章处理费由作者所在机构、资助方或赞助方承担，德国学会的一笔无限制教育资助分担了部分费用。
• The Directory of Open Access Journals lists the title, and Clarivate indexes it in Science Citation Index Expanded, where the 2025 gold open access share of its output is recorded at 100 per cent.该刊被《开放获取期刊目录》收录，Clarivate 将其纳入 SCIE，2025 年其发文的金色开放获取比例记为百分之百。
• Abstracting services reach well beyond medicine, among them Chemical Abstracts, CINAHL, CABI, AGRICOLA, CNKI and Dimensions, a spread that follows the journal's interest in technology and regulation.摘要与索引服务超出医学范围，化学文摘，CINAHL，CABI，AGRICOLA，CNKI 与 Dimensions 都在名单上，这种分布与刊物对技术与法规的关注相称。
• Impact factors have climbed slowly. The 2022 figure was 0.989, 2023 brought 1.1, 2024 reached 1.8 and 2025 closed at 1.9, with a five-year figure of 1.5 and a JCI of 0.56.影响因子的爬升幅度有限，2022 年为 0.989，2023 年为 1.1，2024 年为 1.8，2025 年为 1.9，五年影响因子 1.5，JCI 为 0.56。
• Output stays small, near 28 articles a year in the 2025 count, with 511 citations to the whole run and a cited half-life of 5.3 years, figures that suit a specialist laboratory title.年发文量不大，2025 年统计约 28 篇，全刊累计被引 511 次，引用半衰期 5.3 年，这些数字与一份专科检验刊物的体量相称。
• Volume 50 is being filled during 2026, and the archive from 1977 onward can be reached through the publisher's platform under both the old and the new titles.第 50 卷在 2026 年陆续编定，1977 年以来的存档在出版方平台上可以按新旧两个刊名分别调取。

Editors

• Ralf Lichtinghagen of the Medical University Hannover is editor-in-chief, and the masthead sets six associate editors beside him, from Wuppertal, Munich, Bad Oeynhausen, Heidelberg, Feldkirch and the German Heart Centre in Munich.主编为汉诺威医科大学的（Ralf Lichtinghagen），编头另列六位副编辑，分别来自伍珀塔尔，慕尼黑，巴德恩豪森，海德堡，费尔德基希与慕尼黑德国心脏中心。
• Special issues show how that board is used, since recent ones on routine haematological diagnostics, platelets, paediatric laboratory medicine and liquid profiling each had an issue editor or a pair of guest editors named on the page.专刊可以看出这套班底如何运作，近年的血液学常规诊断，血小板，儿科检验医学与液体活检四组专刊，均在页面上署有执行编辑或两位客座编辑。
• The board is not confined to one country. Beyond a German majority it holds members in Louvain, Antalya, Graz and Perth, so a manuscript on a rare disorder can reach a reader who has seen that disorder.编委不限于一国，除德国多数之外，鲁汶，安塔利亚，格拉茨与珀斯都有成员，罕见病的稿件因此能找到见过该病的人评审。
• Sophia Lamp, working from Greifswald, is managing editor, while the Berlin editorial office is run by Heike Jahnke, who handles the correspondence that authors send during review.执行编辑是（Sophia Lamp），驻格赖夫斯瓦尔德，柏林编辑部由（Heike Jahnke）主持，审稿期间作者的往来信件经她转交。
• Review is single anonymised. At least two experts in the field assess every manuscript, and the editor-in-chief with the editorial team chooses and invites those reviewers.评审采用单盲方式，每篇稿件至少由两位同行专家评估，评审人由主编与编辑团队挑选并发出邀请。
• Reviews pass an extra step, since the associate editors who specialise in the relevant subdiscipline read them and judge whether the argument holds before the external reports are weighed.综述多一道程序，分管相应分支学科的副编辑先读，判断论证是否站得住，再与外部评审意见一并权衡。
• The language policy is strict. Only English-language articles are published, a rule stated plainly among the journal's stated objectives rather than buried in the small print.语言政策严格，刊物只发表英文稿件，这条规定明写在办刊宗旨之中，并未藏在细则的角落。
• Five kinds of paper carry most of the content, namely original research, review, case report, point and counterpoint, and the letter to the editor, and each is assessed by two experts.内容主要由五类稿件承担，原创研究，综述，病例报告，正反方辩论与致编辑信，每一类都经两位专家评估。
• A point and counterpoint exchange sets two signed positions on one contested question side by side in a single issue, a format kept for matters where the evidence has not settled.正反方对话把同一个有争议的问题安排进同一期，两篇署名文章各持一端，这一体例留给证据尚未定论的题目。
• Publication charges are shared with the sponsoring society, whose unrestricted educational grant meets part of the cost of releasing the papers that have been accepted.出版费用与主办学会分担，学会提供的无限制教育资助承担了已录用论文发表的部分开支。
• Correspondence on published work goes to the editorial office in Berlin rather than to an individual editor, and replies are printed with the original letter so the exchange stays readable.针对已刊论文的来信寄往柏林编辑部，不直接寄给某位编辑，答复与原信同期刊出，读者可以顺着读完一轮交锋。